The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 149, Issue 1, 2010, Pages 102-105

  Hefler Frischmuth, Katrin ^a   Seebacher, Veronika ^b   Polterauer, Stephan ^b   Tempfer, Clemens ^b   Reinthaller, Alexander ^b   Hefler, Lukas ^b  

^a WILHELMINEN HOSPITAL   (Austria)

^b UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

Modified Glasgow Prognostic Score (mGPS); Prognosis; Vulvar cancer

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CACHEXIA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GLASGOW PROGNOSTIC SCORE; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; INFLAMMATORY INFILTRATE; LYMPH NODE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; VULVA CANCER;

EID: 76049097218     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.12.027     Document Type: Article

References (40)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 58 (2008) 71-96
2. Messing M.J., and Gallup D.G. Carcinoma of the vulva in young women. Obstet Gynecol 86 (1995) 51-54
3. Joura E.A., Lösch A., Haider-Angeler M.G., Breitenecker G., and Leodolter S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 45 (2000) 613-615
4. Six L., Polterauer S., Grimm C., et al. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer. Eur J Obstet Gynecol Reprod Biol 137 (2008) 217-221
5. Hefler L., Tempfer C., Obermair A., et al. Serum concentrations of vascular endothelial growth factor in vulvar cancer. Clin Cancer Res 5 (1999) 2806-2809
6. Hefler L., Obermair A., Tempfer C., et al. Serum concentrations of squamous cell carcinoma antigen in patients with vulvar intraepithelial neoplasia and vulvar cancer. Int J Cancer 84 (1999) 299-303
7. DiSaia P., Morrow C., Haverback B., and Dyce B. Carcinoembryonic antigen in cervical and vulvar cancer patients. Serum levels and disease progress. Obstet Gynecol 47 (1976) 95-99
8. Burger M.P., Hollema H., Emanuels A.G., Krans M., Pras E., and Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 57 (1995) 327-334
9. Mantovani A., Allavena P., Sica A., and Balkwill F. Cancer-related inflammation. Nature 454 (2008) 436-444
10. Balkwill F., and Coussens L.M. Cancer: an inflammatory link. Nature 431 (2004) 405-406
11. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860
12. Rollins B.J. Inflammatory chemokines in cancer growth and progression. Eur J Cancer 42 (2006) 760-767
13. Hefler-Frischmuth K., Hefler L.A., Heinze G., Paseka V., Grimm C., and Tempfer C.B. Serum C-reactive protein in the differential diagnosis of ovarian masses. Eur J Obstet Gynecol Reprod Biol July (2009)
14. Hefler L.A., Concin N., Hofstetter G., et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 14 3 (2008 Feb 1) 710-714
15. Schmid M., Schneitter A., Hinterberger S., Seeber J., Reinthaller A., and Hefler L. Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer. Obstet Gynecol 110 6 (2007 Dec) 1231-1236
16. Polterauer S., Grimm C., Tempfer C., et al. C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107 (2007) 114-117
17. McMillan D.C., Watson W.S., O'Gorman P., Preston T., Scott H.R., and McArdle G.S. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39 (2001) 210-213
18. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 (2002) 862-871
19. Argiles J.M., Busquets S., and Lopez-Soriano F.J. Cytokines as mediators and targets for cancer cachexia. Cancer Treat Res 130 (2006) 199-217
20. Dixon M.R., Haukoos J.S., Udani S.M., et al. Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 138 (2003) 962-966
21. Goldwasser P., and Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 50 (1997) 693-703
22. Al Murri A.M., Bartlett J.M., Canney P.A., Doughty J.C., Wilson C., and McMillan D.C. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94 (2006) 227-230
23. McMillan D.C. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12 (2009) 223-226
24. Moyes L.H., Leitch E.F., McKee R.F., Anderson J.H., Horgan P.G., and McMillan D.C. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100 (2009) 1236-1239
25. Hill P.G. The measurement of albumin in serum and plasma. Ann Clin Biochem 22 (1985) 565-578
26. Kodama J., Miyagi Y., Seki N., et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 82 (1999) 107-110
27. Hefler L.A., Concin N., Hofstetter G., et al. Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res 14 (2008) 710-714
28. Bonome T., Levine D.A., Shih J., et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res 68 13 (2008) 5478-5486
29. Leitch E.F., Chakrabarti M., Crozier J.E., et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 97 (2007) 1266-1270
30. Leung E.Y., Crozier J.E., Talwar D., et al. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer 123 (2008) 2460-2464
31. Roxburgh C.S., Crozier J.E., Maxwell F., et al. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer 100 (2009) 701-706
32. Crozier J.E., Leitch E.F., McKee R.F., Anderson J.H., Horgan P.G., and McMillan D.C. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Am J Surg 197 (2009) 544-549
33. Roxburgh C.S., Salmond J.M., Horgan P.G., Oien K.A., and McMillan D.C. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249 (2009) 788-793
34. Ramsey S., Lamb G.W., Aitchison M., Graham J., and McMillan D.C. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer 109 (2007) 205-212
35. Forrest L.M., McMillan D.C., McArdle C.S., Angerson W.J., and Dunlop D.J. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 89 (2003) 1028-1030
36. Brown D.J., Milroy R., Preston T., and McMillan D.C. The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer. J Clin Pathol 60 (2007) 705-708
37. Glen P., Jamieson N.B., McMillan D.C., Carter R., Imrie C.W., and McKay C.J. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6 (2006) 450-453
38. Sharma R., Hook J., Kumar M., and Gabra H. Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 44 (2008) 251-256
39. Gonzalez Bosquet J., Magrina J.F., Gaffey T.A., et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 97 (2005) 828-833
40. Woelber L., Mahner S., Voelker K., et al. Clinico-pathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 29 (2009) 545-552